HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Enzyme histochemical and immunohistochemical characterization of oval and parenchymal cells proliferating in livers of rats fed a choline-deficient/DL-ethionine-supplemented diet.

Abstract
Male outbred Sprague-Dawley rats were fed a choline-deficient diet containing 0.10% DL-ethionine for up to 30 weeks. Liver slices from rats killed 4, 6, 10, 14, 22 and 30 weeks after starting the treatment were histochemically analyzed for the following parameters: basophilia, expression of cytokeratin 19 (which in the liver is bile duct epithelial cell-specific), glycogen content and activities of glycogen synthetase (SYN), glycogen phosphorylase (PHO), glucose-6-phosphatase (G6PASE), glucose-6-phosphate dehydrogenase (G6PDH), glyceraldehyde-3-phosphate dehydrogenase (GAPDH), glycerin-3-phosphate dehydrogenase (G3PDH), 'malic enzyme' (MDH), alkaline phosphatase (ALKPASE) and gamma-glutamyltranspeptidase (GGT). The diet induced necrosis of single parenchymal cells and a massive proliferation of oval cells within 4-6 weeks; thereafter cholangiofibroses, cystic cholangiomas and some cholangiofibromas, but no cholangiocarcinomas, were observed. Oval cells, cholangiofibroses, cystic cholangiomas and cholangiofibromas expressed cytokeratin 19, whereas parenchymal cells, foci of altered hepatocytes and hepatocellular adenomas did not; this observation does not support a precursor-product relationship between oval and parenchymal cells. SYN, PHO, G6PASE, G6PDH, GAPDH, G3PDH, MDH, ALKPASE and GGT activities were detected in oval cells; cholangiofibrotic lesions, cystic cholangiomas and cholangiofibromas stained strongly for GAPDH, G3PDH and MDH. In livers from rats fed the diet for 10 weeks, single hepatocytes storing high amounts of glycogen appeared in the parenchyma. There was no indication of a transition from the oval cell population to hepatocytes storing glycogen in excess. Foci of glycogen-storing cells were scattered all over the lobes after 14 and 22 weeks; they had increased G6PASE, G6PDH, ALKPASE and GGT activities. Mixed cell foci and hepatocellular adenomas developed within 22-30 weeks and exhibited a remarkable decrease of G6PASE activity, a strong increase of G6PDH, GAPDH, G3PDH and MDH activities as well as extremely high ALKPASE and GGT activities. The data support the concept that during hepatocarcinogenesis, a number of sequential changes in the activities of various enzymes involved in carbohydrate metabolism occur and that a correlation between morphology and enzyme pattern in the focal lesions does in fact exist. Furthermore, our results suggest that two different cell lineages are involved in the development of cholangiocellular tumors from oval cells and hepatocellular tumors from hepatocytes.
AuthorsP Steinberg, H J Hacker, H P Dienes, F Oesch, P Bannasch
JournalCarcinogenesis (Carcinogenesis) Vol. 12 Issue 2 Pg. 225-31 (Feb 1991) ISSN: 0143-3334 [Print] England
PMID1704820 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Liver Glycogen
  • Keratins
  • Glycerolphosphate Dehydrogenase
  • Malate Dehydrogenase
  • Glucosephosphate Dehydrogenase
  • Glyceraldehyde-3-Phosphate Dehydrogenases
  • gamma-Glutamyltransferase
  • Phosphorylases
  • Glycogen Synthase
  • Alkaline Phosphatase
  • Glucose-6-Phosphatase
  • Ethionine
Topics
  • Alkaline Phosphatase (metabolism)
  • Animal Feed (toxicity)
  • Animals
  • Cell Division (physiology)
  • Choline Deficiency (enzymology)
  • Ethionine (toxicity)
  • Food, Fortified (toxicity)
  • Glucose-6-Phosphatase (metabolism)
  • Glucosephosphate Dehydrogenase (metabolism)
  • Glyceraldehyde-3-Phosphate Dehydrogenases (metabolism)
  • Glycerolphosphate Dehydrogenase (metabolism)
  • Glycogen Synthase (metabolism)
  • Immunohistochemistry
  • Keratins (metabolism)
  • Liver (cytology, enzymology, metabolism)
  • Liver Glycogen (metabolism)
  • Malate Dehydrogenase (metabolism)
  • Male
  • Phosphorylases (metabolism)
  • Rats
  • Rats, Inbred Strains
  • gamma-Glutamyltransferase (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: